Amy E. Tapper - 17 Nov 2021 Form 4 Insider Report for Imago BioSciences, Inc. (IMGO)

Role
Senior Vice President, Non-Clinical and CMC
Signature
/s/ Hugh Rienhoff, as Attorney-in-fact for Amy Tapper
Issuer symbol
IMGO
Transactions as of
17 Nov 2021
Transactions value $
$0
Form type
4
Filing time
19 Nov 2021, 17:04:31 UTC
Previous filing
15 Jul 2021
Next filing
14 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGO Stock Option (Right to Buy) Award $0 +91.5K $0.00 91.5K 17 Nov 2021 Common Stock 91.5K $22.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from November 17, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Remarks:

Senior Vice President, Non-Clinical and CMC